JOYA CHANDRA to Antineoplastic Combined Chemotherapy Protocols
This is a "connection" page, showing publications JOYA CHANDRA has written about Antineoplastic Combined Chemotherapy Protocols.
Connection Strength
0.158
-
Preclinical activity of combined HDAC and KDM1A inhibition in glioblastoma. Neuro Oncol. 2015 Nov; 17(11):1463-73.
Score: 0.104
-
Metachronous Medulloblastoma in a Child With Successfully Treated Neuroblastoma: Case Report and Novel Findings of DNA Sequencing. J Natl Compr Canc Netw. 2018 06; 16(6):683-691.
Score: 0.032
-
Synergistic activity of the SRC family kinase inhibitor dasatinib and oxaliplatin in colon carcinoma cells is mediated by oxidative stress. Cancer Res. 2009 May 01; 69(9):3842-9.
Score: 0.017
-
Adaphostin has significant and selective activity against chronic and acute myeloid leukemia cells. Cancer Sci. 2006 Sep; 97(9):952-60.
Score: 0.004
-
Apoptosis sensitivity in chronic lymphocytic leukemia is determined by endogenous endonuclease content and relative expression of BCL-2 and BAX. J Immunol. 1996 Apr 01; 156(7):2624-30.
Score: 0.002